BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

596 related articles for article (PubMed ID: 32941652)

  • 1. Unbiased investigation of specificities of prime editing systems in human cells.
    Kim DY; Moon SB; Ko JH; Kim YS; Kim D
    Nucleic Acids Res; 2020 Oct; 48(18):10576-10589. PubMed ID: 32941652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Profiling Genome-Wide Specificity of CRISPR-Cas9 Using Digenome-Seq.
    Kim D; Kim JS
    Methods Mol Biol; 2021; 2162():233-242. PubMed ID: 32926386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-wide target specificity of CRISPR RNA-guided adenine base editors.
    Kim D; Kim DE; Lee G; Cho SI; Kim JS
    Nat Biotechnol; 2019 Apr; 37(4):430-435. PubMed ID: 30833658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Off- and on-target effects of genome editing in mouse embryos.
    Ayabe S; Nakashima K; Yoshiki A
    J Reprod Dev; 2019 Feb; 65(1):1-5. PubMed ID: 30518723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TAPE-seq is a cell-based method for predicting genome-wide off-target effects of prime editor.
    Kwon J; Kim M; Bae S; Jo A; Kim Y; Lee JK
    Nat Commun; 2022 Dec; 13(1):7975. PubMed ID: 36581624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide target specificities of CRISPR RNA-guided programmable deaminases.
    Kim D; Lim K; Kim ST; Yoon SH; Kim K; Ryu SM; Kim JS
    Nat Biotechnol; 2017 May; 35(5):475-480. PubMed ID: 28398345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
    Soriano V
    AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FokI-dCas9 mediates high-fidelity genome editing in pigs.
    Fisicaro N; Salvaris EJ; Philip GK; Wakefield MJ; Nottle MB; Hawthorne WJ; Cowan PJ
    Xenotransplantation; 2020 Jan; 27(1):e12551. PubMed ID: 31407391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identifying genome-wide off-target sites of CRISPR RNA-guided nucleases and deaminases with Digenome-seq.
    Kim D; Kang BC; Kim JS
    Nat Protoc; 2021 Feb; 16(2):1170-1192. PubMed ID: 33462439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cas9HF1 enhanced specificity in Ustilago maydis.
    Zuo W; Depotter JR; Doehlemann G
    Fungal Biol; 2020; 124(3-4):228-234. PubMed ID: 32220383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defining genome-wide CRISPR-Cas genome-editing nuclease activity with GUIDE-seq.
    Malinin NL; Lee G; Lazzarotto CR; Li Y; Zheng Z; Nguyen NT; Liebers M; Topkar VV; Iafrate AJ; Le LP; Aryee MJ; Joung JK; Tsai SQ
    Nat Protoc; 2021 Dec; 16(12):5592-5615. PubMed ID: 34773119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engineered prime editors with PAM flexibility.
    Kweon J; Yoon JK; Jang AH; Shin HR; See JE; Jang G; Kim JI; Kim Y
    Mol Ther; 2021 Jun; 29(6):2001-2007. PubMed ID: 33636398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Challenges of in vitro genome editing with CRISPR/Cas9 and possible solutions: A review.
    Ebrahimi V; Hashemi A
    Gene; 2020 Aug; 753():144813. PubMed ID: 32470504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRISPR base editors: genome editing without double-stranded breaks.
    Eid A; Alshareef S; Mahfouz MM
    Biochem J; 2018 Jun; 475(11):1955-1964. PubMed ID: 29891532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a CRISPR/Cas9 System for Methylococcus capsulatus
    Tapscott T; Guarnieri MT; Henard CA
    Appl Environ Microbiol; 2019 Jun; 85(11):. PubMed ID: 30926729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRISPR/Cas9 System and its Research Progress in Gene Therapy.
    Liu W; Yang C; Liu Y; Jiang G
    Anticancer Agents Med Chem; 2019; 19(16):1912-1919. PubMed ID: 31633477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Directed Evolution of CRISPR-Cas9 Base Editors.
    Winter J; Perez-Pinera P
    Trends Biotechnol; 2019 Nov; 37(11):1151-1153. PubMed ID: 31623959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRISPR-Directed Gene Editing Catalyzes Precise Gene Segment Replacement
    Sansbury BM; Wagner AM; Tarcic G; Barth S; Nitzan E; Goldfus R; Vidne M; Kmiec EB
    CRISPR J; 2019 Apr; 2():121-132. PubMed ID: 30998096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Digenome-seq: genome-wide profiling of CRISPR-Cas9 off-target effects in human cells.
    Kim D; Bae S; Park J; Kim E; Kim S; Yu HR; Hwang J; Kim JI; Kim JS
    Nat Methods; 2015 Mar; 12(3):237-43, 1 p following 243. PubMed ID: 25664545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defining CRISPR-Cas9 genome-wide nuclease activities with CIRCLE-seq.
    Lazzarotto CR; Nguyen NT; Tang X; Malagon-Lopez J; Guo JA; Aryee MJ; Joung JK; Tsai SQ
    Nat Protoc; 2018 Nov; 13(11):2615-2642. PubMed ID: 30341435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.